THYROCARE (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE updates the list of securities under the high promoter/non-promoter encumbrance surveillance measure per SEBI SAST Regulation 28(3), … | |||||||||||||||
NSE updates the list of securities under the high promoter/non-promoter encumbrance surveillance measure per SEBI SAST Regulation 28(3), adding Thyrocare Technologies with 75% margin requirement effective May 14, 2026.
| |||||||||||||||
NSE updates the list of securities under surveillance measure for high promoter encumbrance as per SEBI SAST Regulation 28(3), adding 6 … | |||||||||||||||
NSE updates the list of securities under surveillance measure for high promoter encumbrance as per SEBI SAST Regulation 28(3), adding 6 securities effective April 8, 2026 and removing 3 securities effective April 6, 2026.
| |||||||||||||||
NSE notifies listing of further issued securities for 17 companies including ESAF Small Finance Bank, ICICI Bank, Polycab India, and others, … | |||||||||||||||
NSE notifies listing of further issued securities for 17 companies including ESAF Small Finance Bank, ICICI Bank, Polycab India, and others, effective March 17, 2026, allotted primarily under ESOP schemes.
| |||||||||||||||